Skip to main content

heparin

Generic: HEPARIN CALCIUM·Brand: CALCIPARINE, HEPARIN LOCK FLUSH, HEPARIN SODIUM, HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM 1,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM 10,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5%, HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45%, HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%, HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5%, HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.9%, HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM 2,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM 20,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5%, HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM 25,000 UNITS AND DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5%, HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45%, HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9%, HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM 5,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM 5,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.45%, HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9%, HEPARIN SODIUM 5,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM IN PLASTIC CONTAINER, HEPARIN SODIUM PRESERVATIVE FREE, LIPO-HEPIN, LIQUAEMIN LOCK FLUSH, LIQUAEMIN SODIUM, LIQUAEMIN SODIUM PRESERVATIVE FREE, PANHEPRIN, SODIUM HEPARIN

heparin: developed by 1 company · 3 clinical trials tracked · 1 FDA decision.

heparin evidence translation

What we can confirm

1 FDA record · 3 tracked trials

What it means

Source-backed records connect heparin to CASI; that link alone does not prove the drug works.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

How could heparin → CASI affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence0 indications · 3 study sponsors

Related indications

No linked indication is available.

Development Pipeline (1)
CompanyPhase
CASI Pharmaceuticals, Inc (DE) (CASI)Approved
Clinical Trials (3)

A Master Protocol for a Phase 1b Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN9933 and REGN7508, Factor XI Monoclonal Antibodies, and REGN9533, a Factor XII Monoclonal Antibody, in Participants With End-Stage Kidney Disease on Hemodialysis

NCT07759167·Phase 1·REGN
Not yet recruiting

Primary endpoint: Occurrence of Treatment-Emergent Adverse Events (TEAEs)

InterventionalRandomizedquadruple36 targetStarted 2026-09Completion 2027-03Regeneron Pharmaceuticals

A Phase 3, Prospective, Multicenter, Double-Blind, Randomized, Controlled, Adaptive Study To Demonstrate The Safety And Efficacy Of DEFENCATH® In Reducing Central Line-Associated Bloodstream Infections (CLABSIs) In Adult Participants Receiving Total Parenteral Nutrition (TPN) Via Central Venous Catheter (CVC)

NCT06822426·Phase 3·CRMD
Recruiting

Primary endpoint: Comparison between treatment groups of proportion of participants who experience a Central Line-Associated Bloodstream Infections (CLABSI) within 12 months of the start of the study

InterventionalRandomizedtriple200 targetStarted 2025-05Completion 2028-0122 sites · Turkey (Türkiye), United StatesCorMedix Therapeutics

Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency

NCT04227678·N/A·ENTA
Recruiting

Primary endpoint: Organ-specific Dietary Fatty Acid (DFA) partitioning

InterventionalRandomizedsingle16 targetStarted 2019-12Completion 2027-031 site · CanadaUniversité de Sherbrooke
FDA Decisions1 records
Approval(CASI)FDA ↗
ANDA091659Not ApplicableOtherInjectable

Frequently asked questions

Who is developing heparin?

heparin is being developed by CASI Pharmaceuticals, Inc (DE).

How many clinical trials involve heparin?

BioSniper tracks 3 clinical trials involving heparin.

What is heparin's latest FDA decision?

The most recent tracked FDA decision for heparin is Approval, dated June 8, 2011.